
JHVEPhoto/iStock Editorial via Getty Images
Shares of several biotech firms fell in premarket trading Monday after reports that ousted U.S. Food and Drug Administration vaccine regulator Vinay Prasad will return to the agency.
Prasad, who had ordered Sarepta Therapeutics (NASDAQ:SRPT) to halt shipments of